| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |